AbbVie (ABBV)

R&D Expense Growth

-28.89%

Fiscal year · Period ending:

ABBV logo

ABBV R&D Expense Growth

Latest reported-28.89%
ABBV FY R&D Growth (YoY) (0.00% → -28.89%)
High-resolution chart · PNG

ABBV r&d expense growth history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

AbbVie R&D Expense Growth — Annual fiscal periods
Period endingR&D Expense Growth
-28.8875%
66.658%
17.8955%
-19.0902%
3.7524%
14.1784%
-36.8362%
101.5936%
16.3359%
3.3822%
21.5401%
14.2812%
4.1422%
-6.8368%
17.2009%
64.4567%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.